Literature DB >> 9134555

Identification of two genetic markers that distinguish pathogenic and nonpathogenic strains of Acanthamoeba spp.

D K Howe1, M H Vodkin, R J Novak, G Visvesvara, G L McLaughlin.   

Abstract

Species-level identification of Acanthamoeba isolates is difficult and gives little or no indication of the isolate's pathogenicity. We identified two amplification-based genetic markers that were highly correlated with pathogenicity in Acanthamoeba spp. One marker, designed to amplify a 485-bp fragment of the small-subunit ribosomal RNA gene (ssrDNA), was preferentially amplified from the nonpathogenic strains; amplifications from the pathogenic strains yielded anomalous fragments of 650 and 900 bp. A second marker was developed on the basis of the anomalous 650-bp fragment. Primers to this sequence preferentially amplified a noncoding locus (called Ac6) only from the pathogenic strains. These two genetic markers may be useful for identification of pathogenic Acanthamoeba spp. strains.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9134555     DOI: 10.1007/s004360050259

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  13 in total

1.  The identification of free-living environmental isolates of amoebae from Bulgaria.

Authors:  Nina Tsvetkova; Mark Schild; Stefan Panaiotov; Rossitza Kurdova-Mintcheva; Bruno Gottstein; Julia Walochnik; Horst Aspöck; Mar Siles Lucas; Norbert Müller
Journal:  Parasitol Res       Date:  2004-02-04       Impact factor: 2.289

2.  Isolation and identification of pathogenic Acanthamoeba strains in Tenerife, Canary Islands, Spain from water sources.

Authors:  Jacob Lorenzo-Morales; Antonio Ortega-Rivas; Pilar Foronda; Enrique Martínez; Basilio Valladares
Journal:  Parasitol Res       Date:  2005-01-28       Impact factor: 2.289

3.  Use of subgenic 18S ribosomal DNA PCR and sequencing for genus and genotype identification of acanthamoebae from humans with keratitis and from sewage sludge.

Authors:  J M Schroeder; G C Booton; J Hay; I A Niszl; D V Seal; M B Markus; P A Fuerst; T J Byers
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  The use of high-resolution ¹H nuclear magnetic resonance (NMR) spectroscopy in the clinical diagnosis of Acanthamoeba.

Authors:  Sandra Hauber; Hary Parkes; Ruqaiyyah Siddiqui; Naveed Ahmed Khan
Journal:  Parasitol Res       Date:  2011-05-10       Impact factor: 2.289

5.  Fluorescent oligonucleotide probes for clinical and environmental detection of Acanthamoeba and the T4 18S rRNA gene sequence type.

Authors:  D R Stothard; J Hay; J M Schroeder-Diedrich; D V Seal; T J Byers
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

6.  Correlations between morphological, molecular biological, and physiological characteristics in clinical and nonclinical isolates of Acanthamoeba spp.

Authors:  J Walochnik; A Obwaller; H Aspöck
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

7.  Acanthamoeba species isolated from Philippine freshwater systems: epidemiological and molecular aspects.

Authors:  Giovanni D Milanez; Frederick R Masangkay; Patrick Scheid; Joseph D Dionisio; Voravuth Somsak; Manas Kotepui; Jitbanjong Tangpong; Panagiotis Karanis
Journal:  Parasitol Res       Date:  2020-09-12       Impact factor: 2.289

8.  Pathogenic Acanthamoeba spp secrete a mannose-induced cytolytic protein that correlates with the ability to cause disease.

Authors:  Michael Hurt; Sudha Neelam; Jerry Niederkorn; Hassan Alizadeh
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

Review 9.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

Review 10.  Epidemiology of free-living amoebae in the Philippines: a review and update.

Authors:  Giovanni D Milanez; Frederick R Masangkay; Gregorio L Martin I; Ma Frieda Z Hapan; Edilberto P Manahan; Jeffrey Castillo; Panagiotis Karanis
Journal:  Pathog Glob Health       Date:  2022-02-03       Impact factor: 3.735

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.